Akebia Therapeutics (AKBA) Long-Term Deferred Tax (2017 - 2019)
Akebia Therapeutics (AKBA) posted quarterly Long-Term Deferred Tax of $109.4 million for Q4 2019, down 3.04% year-over-year from $112.8 million in Q4 2018, and down 3.04% quarter-over-quarter from $112.8 million in Q4 2018.
Akebia Therapeutics (AKBA) Long-Term Deferred Tax (2017 - 2019) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Long-Term Deferred Tax for 3 consecutive years, with $109.4 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Long-Term Deferred Tax fell 3.04% year-over-year to $109.4 million; the TTM figure through Dec 2019 stood at $109.4 million (down 3.04% YoY), while the FY2019 annual figure was $109.4 million, down 3.04% from the prior year.
- Long-Term Deferred Tax fell to $109.4 million in Q4 2019 per AKBA's latest filing, from $112.8 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $112.8 million in Q4 2018 and bottomed at $400000.0 in Q1 2017.
- Historically, Long-Term Deferred Tax has averaged $74.2 million across 3 years, with a median of $109.4 million in 2019.
- On a YoY basis, Long-Term Deferred Tax climbed as much as 3.04% in 2019 and fell as far as 3.04% in 2019.
- Akebia Therapeutics' Long-Term Deferred Tax stood at $400000.0 in 2017, then surged by 28094.25% to $112.8 million in 2018, then retreated by 3.04% to $109.4 million in 2019.
- Business Quant data shows AKBA's Long-Term Deferred Tax at $109.4 million in Q4 2019, $112.8 million in Q4 2018, and $400000.0 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Akebia Therapeutics | 247.60 Mn | 92.06 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 109.35 Mn |
| Dec 31, 2018 | 112.78 Mn |
| Mar 31, 2017 | 400,000.00 |